Kymera Therapeutics, Inc. · NASDAQ:KYMR
BlackRock, Inc. reported a 5.40% stake in Kymera Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 5.40% stake in Kymera Therapeutics, Inc., 3,803,227 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G/A).
- Stake
- 5.40%
- Shares
- 3,803,227
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.40% | 3,803,227 |
Source
Related
- Kymera Therapeutics, Inc.
- BlackRock, Inc.
- Kymera Therapeutics, Inc. shareholders
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026